| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |